| Date | Time | Source | Headline | Symbol | Company |
| 07/11/2024 | 12:21PM | iHub Newswire | FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing | | |
| 12/19/2008 | 8:15PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/19/2008 | 6:14PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/19/2008 | 6:12PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/19/2008 | 4:53PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/19/2008 | 4:49PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/19/2008 | 4:41PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/19/2008 | 4:16PM | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/19/2008 | 12:59PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/18/2008 | 8:52AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/18/2008 | 8:30AM | Business Wire | Ardea Biosciences Announces $30.6 Million Private Placement | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/16/2008 | 2:50PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/16/2008 | 2:50PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 11/20/2008 | 8:30AM | Business Wire | Ardea Biosciences to Present at the 20th Annual Piper Jaffray Healthcare Conference | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 11/13/2008 | 5:25PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 11/13/2008 | 3:08PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 11/13/2008 | 8:30AM | Business Wire | Ardea Biosciences Secures $8 Million Growth Capital Loan | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 11/13/2008 | 8:30AM | Business Wire | Ardea Biosciences Announces Progress of Clinical Development Programs & Reports Third Quarter & Year-to-Date 2008 Financial R... | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 10/29/2008 | 8:00AM | Business Wire | Ardea Biosciences to Present at the Oppenheimer 19th Annual Healthcare Conference & the Lazard Capital Markets 5th Annual Hea... | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 10/27/2008 | 8:00AM | Business Wire | Ardea Biosciences Presents Preliminary Data from a Phase 1 Study of RDEA594 at the 2008 ACR/ARHP Annual Scientific Meeting | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 10/27/2008 | 8:00AM | Business Wire | Ardea Biosciences Presents Additional Phase 2a & Preclinical Data on its Lead HIV Product Candidate, RDEA806, at the 48th Ann... | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 10/24/2008 | 8:08AM | Business Wire | Ardea Biosciences to Present Clinical Data on its Lead MEK Inhibitor, RDEA119, at the ASCO–NCI–EORTC 2nd Annual Meeting o... | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 10/24/2008 | 8:07AM | Business Wire | Ardea Biosciences Presents Preclinical Data on its Lead MEK Inhibitor, RDEA119, Demonstrating Synergy with Other Anti-Cancer ... | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 10/20/2008 | 8:00AM | Business Wire | Ardea Biosciences Awarded Composition of Matter Patent Covering RDEA806, Its Lead NNRTI for the Treatment of HIV | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 10/16/2008 | 8:00AM | Business Wire | Ardea Biosciences Initiates a Phase 1/2 Study of RDEA119, its Lead MEK Inhibitor, in Combination with Nexavar® (sorafenib) i... | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 10/15/2008 | 5:28PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 10/07/2008 | 8:00AM | PR Newswire (US) | Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 09/19/2008 | 7:52PM | Edgar (US Regulatory) | Ardea Biosciences, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 09/17/2008 | 8:00AM | PR Newswire (US) | Ardea Biosciences to Present at the UBS Global Life Sciences Conference and the Third Annual JMP Securities Healthcare Focus Con | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 09/16/2008 | 8:00AM | PR Newswire (US) | Ardea Biosciences to Present Data on Gout and Inflammation Programs at the 2008 ACR/ARHP Annual Scientific Meeting | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |